A Seattle-based privately held biotechnology company identifying and developing therapeutic compounds for the treatment of human disease, founded in 1995, Icogen was renamed Icogenex in 2003. The Company's operations have been financed through investments, contracts, and grant support from the National Institutes of Health

Biotechnology

Health Care

Pharmaceutical

Icogenex

Icogenex's headquarters in Seattle, WA, United States

Frederick S. Hagen

Jerry McGuire

James B. Glavin

Niels H. Andersen

Julian A. Simon

George M. Martin

Description

People (2)

Frederick S. Hagen

Pema Ngoenga

Jobs